Literature DB >> 26160874

COPD comorbidities network.

Miguel J Divo1, Ciro Casanova2, Jose M Marin3, Victor M Pinto-Plata4, Juan P de-Torres5, Javier J Zulueta5, Carlos Cabrera6, Jorge Zagaceta5, Pablo Sanchez-Salcedo5, Juan Berto5, Rebeca Baz Davila2, Ana B Alcaide5, Claudia Cote7, Bartolome R Celli4.   

Abstract

Multimorbidity frequently affects the ageing population and their co-existence may not occur at random. Understanding their interactions and that with clinical variables could be important for disease screening and management.In a cohort of 1969 chronic obstructive pulmonary disease (COPD) patients and 316 non-COPD controls, we applied a network-based analysis to explore the associations between multiple comorbidities. Clinical characteristics (age, degree of obstruction, walking, dyspnoea, body mass index) and 79 comorbidities were identified and their interrelationships quantified. Using network visualisation software, we represented each clinical variable and comorbidity as a node with linkages representing statistically significant associations.The resulting COPD comorbidity network had 428, 357 or 265 linkages depending on the statistical threshold used (p≤0.01, p≤0.001 or p≤0.0001). There were more nodes and links in COPD compared with controls after adjusting for age, sex and number of subjects. In COPD, a subset of nodes had a larger number of linkages representing hubs. Four sub-networks or modules were identified using an inter-linkage affinity algorithm and their display provided meaningful interactions not discernible by univariate analysis.COPD patients are affected by larger number of multiple interlinked morbidities which clustering pattern may suggest common pathobiological processes or be utilised for screening and/or therapeutic interventions.
Copyright ©ERS 2015.

Entities:  

Mesh:

Year:  2015        PMID: 26160874     DOI: 10.1183/09031936.00171614

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  46 in total

1.  Assessment of Cognitive Impairment in Patients with Chronic Obstructive Pulmonary Disease Using the Rapid Cognitive Screen.

Authors:  E Charbek; K Huynh; E Kim; R P Nayak
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

Review 2.  Imaging approaches to understand disease complexity: chronic obstructive pulmonary disease as a clinical model.

Authors:  Karin J C Sanders; Samuel Y Ash; George R Washko; Felix M Mottaghy; Annemie M W J Schols
Journal:  J Appl Physiol (1985)       Date:  2017-07-27

3.  Multimorbidity medications and poor asthma prognosis.

Authors:  Sébastien Chanoine; Margaux Sanchez; Isabelle Pin; Sofia Temam; Nicole Le Moual; Agnès Fournier; Christophe Pison; Jean Bousquet; Pierrick Bedouch; Marie-Christine Boutron-Ruault; Raphaëlle Varraso; Valérie Siroux
Journal:  Eur Respir J       Date:  2018-04-12       Impact factor: 16.671

4.  Multimorbidity and chronic co-prescription networks and potential interactions in adult patients with epilepsy: MorbiNet study.

Authors:  Ferran Moratalla-Navarro; Victor Moreno; Flora López-Simarro; Maria Estrella Barceló; Alba Aguado
Journal:  Neurol Sci       Date:  2022-09-05       Impact factor: 3.830

Review 5.  Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance.

Authors:  Lloyd Tanner; Andrew Bruce Single
Journal:  J Innate Immun       Date:  2019-09-17       Impact factor: 7.349

6.  Relationship between Emphysema Progression at CT and Mortality in Ever-Smokers: Results from the COPDGene and ECLIPSE Cohorts.

Authors:  Samuel Y Ash; Raúl San José Estépar; Sean B Fain; Ruth Tal-Singer; Robert A Stockley; Lars H Nordenmark; Stephen Rennard; MeiLan K Han; Debora Merrill; Stephen M Humphries; Alejandro A Diaz; Stefanie E Mason; Farbod N Rahaghi; Carrie L Pistenmaa; Frank C Sciurba; Gonzalo Vegas-Sánchez-Ferrero; David A Lynch; George R Washko
Journal:  Radiology       Date:  2021-02-16       Impact factor: 11.105

7.  Distinguishing Smoking-Related Lung Disease Phenotypes Via Imaging and Molecular Features.

Authors:  Ehab Billatos; Samuel Y Ash; Fenghai Duan; Ke Xu; Justin Romanoff; Helga Marques; Elizabeth Moses; MeiLan K Han; Elizabeth A Regan; Russell P Bowler; Stefanie E Mason; Tracy J Doyle; Rubén San José Estépar; Ivan O Rosas; James C Ross; Xiaohui Xiao; Hanqiao Liu; Gang Liu; Gauthaman Sukumar; Matthew Wilkerson; Clifton Dalgard; Christopher Stevenson; Duncan Whitney; Denise Aberle; Avrum Spira; Raúl San José Estépar; Marc E Lenburg; George R Washko
Journal:  Chest       Date:  2020-09-16       Impact factor: 10.262

8.  Adherence to a COPD treatment guideline among patients in Hong Kong.

Authors:  Ka Pang Chan; Fanny Ws Ko; Hok Sum Chan; Mo Lin Wong; Thomas Yw Mok; Kah Lin Choo; David Sc Hui
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-11-28

9.  What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.

Authors:  Stefan Karrasch; Irene Brüske; Maia P Smith; Barbara Thorand; Cornelia Huth; Karl-Heinz Ladwig; Florian Kronenberg; Joachim Heinrich; Rolf Holle; Annette Peters; Holger Schulz
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-08-16

10.  Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: Evidence from the EpiChron Cohort.

Authors:  Miguel J Divo; Bartolome R Celli; Beatriz Poblador-Plou; Amaia Calderón-Larrañaga; Juan Pablo de-Torres; Luis A Gimeno-Feliu; Juan Bertó; Javier J Zulueta; Ciro Casanova; Victor M Pinto-Plata; Carlos Cabrera-Lopez; Francesca Polverino; Jonás Carmona Píréz; Alexandra Prados-Torres; Jose M Marin
Journal:  PLoS One       Date:  2018-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.